A majority of women who completed monthly prenatal urine tests at home using Tel Aviv-based Healthy.io's smartphone app not only found the process simple, but preferred it to in-clinic testing, according to a study published in the American Journal of Obstetrics and Gynecology.
In the study, led by researchers from Johns Hopkins University School of Medicine in Baltimore, 179 pregnant women were given the option to use Healthy.io's Dip.io digital urinalysis program. Of the participants who attempted to use Dip.io, 96 percent successfully completed the test. Additionally, 96 percent of those who completed an accompanying survey said they found the system easy or very easy to use, and more than 60 percent said they preferred the at-home method to traditional in-clinic testing.
The FDA-cleared Dip.io uses a smartphone camera and computer vision-powered app to analyze a user's sample; the system measures 10 parameters indicative of infections, illnesses and other pregnancy-related complications. Those results are then automatically sent to the user's providers and uploaded to their EHR.
More articles about health IT:
Beth Israel Deaconess' open-source patient database enabled a decade of AI research
VA appoints 1st director of AI, plans to expand AI research: 4 notes
The life of a scribe — 2 experts detail the most important skill to have